Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges.

MLA

Laokulrath, Natthawadee, et al. “Human Epidermal Growth Factor Receptor 2 (HER2) Status in Breast Cancer: Practice Points and Challenges.” Histopathology, vol. 85, no. 3, Sept. 2024, pp. 371–82. EBSCOhost, https://doi.org/10.1111/his.15213.

APA

Laokulrath, N., Gudi, M., Salahuddin, S. A., Chong, A. P. Y., Ding, C., Iqbal, J., Leow, W. Q., Tan, B. Y., Tse, G., Rakha, E., & Tan, P. H. (2024). Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges. Histopathology, 85(3), 371–382. https://doi.org/10.1111/his.15213

Chicago

Laokulrath, Natthawadee, Mihir Gudi, Syed Ahmed Salahuddin, Angela Phek Yoon Chong, Cristine Ding, Jabed Iqbal, Wei Qiang Leow, et al. 2024. “Human Epidermal Growth Factor Receptor 2 (HER2) Status in Breast Cancer: Practice Points and Challenges.” Histopathology 85 (3): 371–82. doi:10.1111/his.15213.